Dr. Peter M. Kaye, MD

Dr. Kaye practices at Stamford Health Medical Group, Inc. in Stamford, Connecticut.

Dr. Kaye's NPI, 1770757882, was assigned on April 18, 2008. Dr. Kaye graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2002. Dr. Kaye holds New York license 229839.

Dr. Kaye's primary practice is Stamford Health Medical Group, Inc., at 1 Omega Dr, Stamford, CT 06907 in Western Ct County. The practice phone is (203) 276-7447.

Dr. Kaye's primary practice is Stamford Health Medical Group, Inc. in Stamford, Connecticut. Dr. Kaye is also affiliated with Stamford Hospital. The medical group on file is Stamford Health Medical Group. Dmand AI also links Dr. Kaye to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kaye practices, 2 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Kaye's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Kaye is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Kaye's licenses on file in 4 states: New York, New Jersey, Connecticut and Ohio.

Dmand AI lists colonoscopy, colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Kaye treats.

CMS data shows 440 Medicare services from Dr. Kaye across 8 procedure codes in 2024, for 224 Medicare patients. Medicare paid $36,949 for them.

CMS counts 224 Medicare patients who saw Dr. Kaye in 2024. The largest group is 75 to 84, with 93 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.67, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kaye's median patient age at 56, with 45% women.

In 2024, Dr. Kaye wrote 197 Medicare Part D claims for 76 patients. 77% of them were for generic drugs. CMS names the drug for 90 of them, across 4 drugs with 11 or more claims each, at $10,264 in total drug cost. In 2023, CMS named 61 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Kaye for performance year 2024, reported through an alternative payment model (APM). Dr. Kaye accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 16 procedures of colonoscopy by Dr. Kaye, more than 45% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Kaye in 2022. Dr. Kaye's most frequent co-authors are Alexander J. Fortgang, DO, Jason Lim, MD and Anna Serur, MD.

CMS Open Payments shows 84 general payments to Dr. Kaye from 30 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Smith & Nephew, Inc. paid the most, $189.

Dmand AI lists 1 award for Dr. Kaye, most recently CMS Stage 1 EHR in 2014.

Dr. Kaye graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2002. Dr. Kaye is a member of ACS and ASCRS.

Dr. Kaye is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.